Cell and gene therapies are at the forefront of innovation and have the potential to radically change healthcare with increased accessibility. Membio is on a mission to make the manufacturing of cell and gene therapies more cost effective. We’re doing this by developing a biomanufacturing platform that will enable the cost-effective and scalable production of whole cells for use in cell and gene therapies.